SEC warns pharma companies to be honest about FDA correspondence

March 3, 2015 10:41 PM

6 0

WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission's top enforcement chief warned on Tuesday that too many pharmaceutical companies are failing to accurately portray their dealings with federal drug regulators - a problem that could get them in trouble.

Andrew Ceresney, the SEC's enforcement director, said the agency has seen a lot of problems with disclosures by pharmaceutical companies, including on 8-Ks - a form companies file when they need to disclose an event that is "material" to their business.

Also read: A 20-year-old is shot to death. Now police need help finding out who did it

Read more

To category page

Loading...